ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Renascience, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -238.51
- Poor long term growth as Operating profit has grown by an annual rate 0.90% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -238.51
- The company has reported losses. Due to this company has reported negative ROE
3
Poor long term growth as Operating profit has grown by an annual rate 0.90% of over the last 5 years
4
The company has declared Negative results for the last 4 consecutive quarters
- NET SALES(HY) At JPY 58.55 MM has Grown at -23.9%
- PRE-TAX PROFIT(Q) At JPY -82.71 MM has Fallen at -117.5%
- NET PROFIT(Q) At JPY -82.96 MM has Fallen at -110%
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -50.44%, its profits have fallen by -53.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Renascience, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Renascience, Inc.
-58.93%
3.50
91.09%
Japan Nikkei 225
60.14%
2.04
29.37%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.17%
EBIT Growth (5y)
0.90%
EBIT to Interest (avg)
-268.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.05
Sales to Capital Employed (avg)
0.07
Tax Ratio
0.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.04
EV to EBIT
-66.04
EV to EBITDA
-66.05
EV to Capital Employed
-19419.22
EV to Sales
181.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-10.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at JPY -149.55 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-22What is not working for the Company
NET SALES(HY)
At JPY 58.55 MM has Grown at -23.9%
PRE-TAX PROFIT(Q)
At JPY -82.71 MM has Fallen at -117.5%
NET PROFIT(Q)
At JPY -82.96 MM has Fallen at -110%
Here's what is working for Renascience, Inc.
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Renascience, Inc.
Net Sales
At JPY 58.55 MM has Grown at -23.9%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (JPY MM)
Pre-Tax Profit
At JPY -82.71 MM has Fallen at -117.5%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Profit
At JPY -82.96 MM has Fallen at -110%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
